These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10363743

  • 1. The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
    Jansson K, Dahlström U, Karlberg BE, Karlsson E, Nylander E, Nyquist O, Karlberg KE.
    J Intern Med; 1999 May; 245(5):435-43. PubMed ID: 10363743
    [Abstract] [Full Text] [Related]

  • 2. More favourable haemodynamic effects from metoprolol than from captopril in patients with dilated cardiomyopathy.
    Jansson K, Karlberg KE, Nylander E, Karlsson E, Nyquist O, Dahlström U.
    Eur Heart J; 1997 Jul; 18(7):1115-21. PubMed ID: 9243145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.
    Fung JW, Yu CM, Yip G, Chan S, Yandle TG, Richards AM, Nicholls MG, Sanderson JE.
    Am J Cardiol; 2003 Aug 15; 92(4):406-10. PubMed ID: 12914870
    [Abstract] [Full Text] [Related]

  • 5. The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy.
    Jansson K, Hagerman I, Ostlund R, Karlberg KE, Nylander E, Nyquist O, Dahlström U.
    Clin Cardiol; 1999 Jun 15; 22(6):397-402. PubMed ID: 10376178
    [Abstract] [Full Text] [Related]

  • 6. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y, Hasegawa K, Sawayama T, Inoue S, Nakamura T, Kakumae S, Tadaoka S, Nakao M, Nezuo S.
    Kokyu To Junkan; 1989 Dec 15; 37(12):1333-40. PubMed ID: 2575781
    [Abstract] [Full Text] [Related]

  • 7. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    Kinugawa T, Kato M, Mori M, Endo A, Kato T, Hamada T, Noguchi N, Omodani H, Osaki S, Ogino K, Miyakoda H, Hisatome I, Shigemasa C.
    Eur J Clin Pharmacol; 1998 May 15; 54(3):209-14. PubMed ID: 9681661
    [Abstract] [Full Text] [Related]

  • 8. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, Heras M, Sanz G.
    Eur Heart J; 2000 Jan 15; 21(1):53-7. PubMed ID: 10610744
    [Abstract] [Full Text] [Related]

  • 9. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T, Endo A, Kato M, Kato T, Ahmmed GU, Omodani H, Osaki S, Ogino K, Hisatome I, Miyakoda H, Fujimoto Y, Yoshida A, Shigemasa C.
    Cardiology; 1997 Jan 15; 88(3):238-45. PubMed ID: 9129844
    [Abstract] [Full Text] [Related]

  • 10. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
    Kinugawa T, Osaki S, Kato M, Ogino K, Shimoyama M, Tomikura Y, Igawa O, Hisatome I, Shigemasa C.
    Clin Exp Pharmacol Physiol; 2002 Dec 15; 29(12):1060-5. PubMed ID: 12390293
    [Abstract] [Full Text] [Related]

  • 11. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition.
    Eiskjaer H, Bagger JP, Mogensen CE, Schmitz A, Pedersen EB.
    Scand J Clin Lab Invest; 1992 May 15; 52(3):193-9. PubMed ID: 1411251
    [Abstract] [Full Text] [Related]

  • 12. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F, Strömblad O, Andersson B, Böhm M, Darius M, Delius W, Goss F, Osterziel KJ, Sigmund M, Trenkwalder SP, Wahlqvist I.
    Eur J Heart Fail; 2003 Oct 15; 5(5):679-91. PubMed ID: 14607208
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Oct 15; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 17. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
    Coletta C, Ricci R, Ceci V, Seccareccia F, Rulli F, Mazzuca V, Putini RL, Salustri A, Bottero G, Pasquale M.
    G Ital Cardiol; 1999 Feb 15; 29(2):115-24; discussion 125-9. PubMed ID: 10088066
    [Abstract] [Full Text] [Related]

  • 18. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T, Ogino K, Kitamura H, Saitoh M, Omodani H, Osaki S, Hisatome I, Miyakoda H.
    Am J Med Sci; 1996 Sep 15; 312(3):110-7. PubMed ID: 8783676
    [Abstract] [Full Text] [Related]

  • 19. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM, Pinto F, Ravara L, van Zwieten PA.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 15; 5(3):121-9. PubMed ID: 15526247
    [Abstract] [Full Text] [Related]

  • 20. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.